Abstract
For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.
Original language | English |
---|---|
Journal | Nature Reviews Endocrinology |
Volume | 11 |
Issue number | 6 |
Pages (from-to) | 327-8 |
Number of pages | 2 |
ISSN | 1759-5029 |
DOIs | |
Publication status | Published - 26 Jun 2015 |
Keywords
- Diabetes, Gestational
- Female
- Glyburide
- Humans
- Hypoglycemic Agents
- Insulin
- Metformin
- Pregnancy